Plain-English translation of NCT07469709 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This research study is trying to understand why some people develop cancer and why some cancers come back after treatment. Researchers will examine blood samples and tumor tissue from people with several types of cancer—including breast, ovarian, colorectal, melanoma, and lung cancer—to look for genetic changes and immune system patterns that might predict cancer risk. By studying these biological markers, doctors hope to better identify which patients are most at risk and potentially catch cancer recurrence earlier.
Many cancers run in families, but doctors don't yet fully understand all the genetic and biological reasons why some people get cancer while others don't—or why recurrence happens in some patients and not others. This study aims to fill that gap by identifying patterns in genes and immune cells that could help doctors predict individual cancer risk and improve how they monitor and treat cancer survivors.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will meet with a genetic counselor or oncology specialist who will explain genetic testing and discuss your personal and family cancer history. You will provide a 5-milliliter blood sample (about a teaspoon) for DNA and RNA analysis. Depending on which group you are placed in, doctors may also examine your tumor tissue that was removed during surgery to study immune cells and other biological markers. The study has both a one-time component and a longer-term monitoring component, though specific visit schedules are still being finalized.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Italy